Dealer Address]Electronic Arts Inc. • July 20th, 2011 • Services-prepackaged software
Company FiledJuly 20th, 2011 IndustryThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [Dealer] (“Dealer”) and Electronic Arts Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for the Transaction.
JPMorgan Chase Bank, National AssociationGilead Sciences Inc • November 8th, 2010 • Biological products, (no disgnostic substances)
Company FiledNovember 8th, 2010 IndustryThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between JPMorgan Chase Bank, National Association, London Branch (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
August 5, 2010Gilead Sciences Inc • November 8th, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledNovember 8th, 2010 Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between Goldman, Sachs & Co. (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
Goldman, Sachs & Co. New York, New York 10282-2198 Telephone No.: (212) 902-1000 August 5, 2010 To: Gilead Sciences, Inc. Foster City, California 94404 Attention: Treasurer Telephone No.: (650) 522-5727 Facsimile No.: (650) 522-3000 A/C: 028820868...Gilead Sciences Inc • November 8th, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledNovember 8th, 2010 Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between Goldman, Sachs & Co. (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
JPMorgan Chase Bank, National Association London EC4Y 0JP EnglandGilead Sciences Inc • August 9th, 2010 • Biological products, (no disgnostic substances)
Company FiledAugust 9th, 2010 IndustryThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between JPMorgan Chase Bank, National Association, London Branch (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
JPMorgan Chase Bank, National Association London EC4Y 0JP EnglandGilead Sciences Inc • August 9th, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledAugust 9th, 2010 Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between JPMorgan Chase Bank, National Association, London Branch (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
Goldman, Sachs & Co.Gilead Sciences Inc • August 9th, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledAugust 9th, 2010 Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between Goldman, Sachs & Co. (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
Goldman, Sachs & Co. New York, New York 10282-2198 Telephone No.: (212) 902-1000Gilead Sciences Inc • August 9th, 2010 • Biological products, (no disgnostic substances) • New York
Company FiledAugust 9th, 2010 Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between Goldman, Sachs & Co. (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.